- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02308566
Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound (AKE-MECC)
Aortic Valve Replacement Using Closed Extracorporeal Circuit. Minimized Versus Conventional Extracorporeal Circulation Technique: Qualitative Differences
Studieoversikt
Status
Detaljert beskrivelse
Background
The gold standard to treat severe aortic valve stenosis is currently the surgical aortic valve replacement (SAVR) using conventional extracorporeal circulation (CECC). SAVR, however, can be performed also on minimized extracorporeal circulation (MECC), which is characterized by reduced priming volume and interfaces between blood and artificial surfaces and blood-air interface, respectively. Further technical developments of the MECC system together with reports on less induction of the coagulation cascade and activation of inflammatory systemic response may account for a reduced incidence of microbubble generation with MECC system.
Objective
The aim of the is to investigate the procedural-related incidence of high-intensity transient signals (HITS) representing solid or gaseous microembolism reaching the cerebral vessels.
Methods
Patients undergoing SAVR are included in the study and randomised to either MECC or CECC technique. HITS are continuously bilaterally detected during the entire intraoperative period by transcranial Doppler ultrasound.
Studietype
Registrering (Faktiske)
Fase
- Fase 4
Kontakter og plasseringer
Studiesteder
-
-
-
Bern, Sveits, 3010
- University Hospital Bern
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Isolated Severe Aortic Valve Stenosis
- No other cardiac disease
- No other coronary heart disease
- Written informed consent
Exclusion Criteria
- Double valve surgery
- Concomitant coronary artery bypass surgery
- Vascular surgery
- Age < 18 yrs.
- Age > 80 yrs.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Conventional Extracorporeal Circulation Technique
|
This group of patients receives surgical aortic valve replacement using CECC.
|
|
Eksperimentell: Minimized Extracorporeal Circulation Technique
|
This group of patients receives surgical aortic valve replacement using MECC.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Total and interval-related cerebral microembolic load as measured by transcranial Doppler
Tidsramme: Intraoperative period (start surgical procedure to skin suture, duration approx. 4 hrs)
|
Intraoperative period (start surgical procedure to skin suture, duration approx. 4 hrs)
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Cerebral complications, e.g. delirium and stroke as detected clinically
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
|
Redo surgery
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
|
ICU length of stay
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
|
Extubation time
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
|
Thromboembolic complications
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
|
In-hospital infections
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
|
In-hospital Mortality
Tidsramme: In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
In-hospital period (until hospital discharge, duration approx. 7-10 days)
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Thierry Carrel, MD, PhD, Department of Cardiovascular Surgery
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 034/11
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Aortaklaffstenose
-
IRCCS Policlinico S. DonatoRekrutteringAnomalous aortic origin of the coronary artery (AAOCA)Italia
-
Mahidol UniversityFullført
-
China National Center for Cardiovascular DiseasesRekrutteringDe Novo Stenosis | Medikamentbelagt ballong | Medikamentavgivende stentKina
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaAktiv, ikke rekrutterendePCI | De Novo Stenosis | DCBItalia
-
Napa Pain InstituteVertos Medical, Inc.FullførtLumbal Spine Stenosis Central CanalForente stater
-
Zunyi Medical CollegeFullførtAkutt koronarsyndrom | De Novo StenosisKina
-
Xijing HospitalAktiv, ikke rekrutterendeKoronararteriesykdom | De Novo StenosisKina
-
Xijing HospitalRekrutteringKoronararteriesykdom | De Novo StenosisKina
-
Xijing HospitalAktiv, ikke rekrutterendeKoronararteriesykdom | Perkutan koronar intervensjon | De Novo StenosisKina
-
Genoss Co., Ltd.FullførtPerifer arteriesykdom | De Novo StenosisKorea, Republikken